Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

FDG PET/CT and cervical cancer

By Kristin Schmiedehausen, MD

|2015-01-02

Cervical cancer is the fourth most common cancer in women.1 PET/CT in addition with Fludeoxyglucose F18 injection (18F FDG) can be used together to promote the use of PET/CT for personalized treatment triage and planning, which could possibly impact therapy management and follow-up for patients with cervical cancer. Download the white paper below to learn more about the role of FDG PET/CT and cervical cancer, in addition to more information on national cancer guidelines and reimbursement policies.

1